ArticleSignal transduction and targeted therapy2025

A first-in-class selective inhibitor of ERK1/2 and ERK5 overcomes drug resistance with a single-molecule strategy.

Huan Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.